Loading: 100%
Mylan N.V. logo
no logo available
General Information
Investor relations pageIR page no data available
Founding year no data available
Headquarter , , no data available
Employees 35,000 (as per FY 2014)no data available
Sector Drug Manufacturers, HealthcareDrug Manufacturers, Healthcareno data available
Ticker MYLno data available
Financial year endsFY ends End of Decemberno data available
Stock Information (historical prices adjusted for splits and dividends)
Adj. Closing prices (in USD) -Common sharesNov. 16Jan. 17März 17Mai 17Juli 17Sep. 173034384246
datesClosing price (adj.)
13.10.201737.95
11.10.201738.29
04.10.201737.80
27.09.201731.93
20.09.201731.39
13.09.201733.56
06.09.201732.25
30.08.201730.59
23.08.201730.32
16.08.201730.47
09.08.201732.08
02.08.201736.92
26.07.201739.19
19.07.201738.34
12.07.201738.58
05.07.201738.47
27.06.201738.43
20.06.201737.42
13.06.201737.77
06.06.201738.55
30.05.201739.36
23.05.201739.59
16.05.201739.15
09.05.201738.01
02.05.201738.17
25.04.201736.85
18.04.201737.03
11.04.201738.45
04.04.201738.70
28.03.201741.72
21.03.201741.67
14.03.201742.77
07.03.201743.33
28.02.201741.85
21.02.201742.30
14.02.201740.75
07.02.201739.39
31.01.201738.05
24.01.201735.81
17.01.201737.07
10.01.201738.95
03.01.201739.11
27.12.201637.58
19.12.201637.49
12.12.201637.13
05.12.201635.65
28.11.201636.74
21.11.201636.68
14.11.201638.44
07.11.201636.59
31.10.201636.50
24.10.201637.56
17.10.201636.44
no share price data source found
Share price data requested
Key Figures
Last Closing Price
as per Oct 13, 2017, in USD
37.95n/a
Market Capitalisation
in million USD
14,204n/a
Enterprise Value
in million USD
22,536n/a
Common Shares Outstanding
as per Oct 29, 2014
374,273,573n/a
Preferred Shares Outstanding
as per Oct 29, 2014
n/a
Average Basic Shares Outstanding
TTM
373,700,000n/a
Average Diluted Shares Outstanding
TTM
398,000,000n/a
Index Membership
n/a
Business Summary
Mylan NV is a generic pharmaceutical manufacturer which develops, licenses, manufactures, markets and distributes generic, over-the-counter (OTC) products in a variety of dosage forms and therapeutic categories.
no data available
Key Financials & Ratios (all figures TTM as per Dec 31, 2014, million USD, full statements further below)
Profit & Loss
Revenues 7,720n/a
Gross Profit 3,528n/a
Operating Income 1,321n/a
EBITDA 1,887n/a
Net Profit 929n/a
Balance Sheet
Cash and Cash Equivalents 226n/a
Receivables 2,269n/a
Total Current Assets 6,787n/a
PP&E 1,786n/a
Total Assets 15,887n/a
Accounts Payable 906n/a
Current Debt 2,805n/a
Total Current Liabilities 5,306n/a
Long-Term Debt 5,733n/a
Total Liabilities 12,611n/a
Total Equity 3,276n/a
Cash Flow
Depreciation & Amortisation 567n/a
Change in Working Capital -1,182n/a
Operating Cash Flow 1,015n/a
Net Change in PP&E and Intangibles -316n/a
Investing Cash Flow -800n/a
Dividends Paid 0n/a
Financing Cash Flow -267n/a
Total Change in Cash -66n/a
Free Cash Flow 348n/a
Profitability Ratios
Gross Margin 45.7%n/a
Operating Margin 17.1%n/a
Net Profit Margin 12.1%n/a
Return on Equity 28.5%n/a
Return on Assets 5.9%n/a
Per Share Figures
Basic EPS 2.49n/a
Diluted EPS 2.34n/a
Sales per Share 20.66n/a
Book Value per Share 8.71n/a
FCF per Share 0.93n/a
Dividends per Share 0.00n/a
Price Multiples
Price to Earnings Ratio 15.26n/a
Price to Sales Ratio 1.84n/a
Price to Book Value 4.33n/a
Price to Free Cash Flow 40.78n/a
Valuation Metrics
EV/EBITDA 11.94n/a
EV/Sales 2.92n/a
Book to Market Value 0.23n/a
Other Ratios
Current Ratio 127.9%n/a
Liabilities to Equity Ratio 384.9%n/a
Debt to Assets Ratio 53.7%n/a
Profit & Loss StatementP&L data quality: 100% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
No data available for the selected time periods
in million USD FY '08FY '09FY '10FY '11FY '12FY '13FY '14
Revenue
5,138
5,093
5,451
6,130
6,796
6,909
7,720
Sales & Services Revenue
0
0
0
0
0
0
0
Financing Revenue
0
0
0
0
0
0
0
Other Revenue
0
0
0
0
0
0
0
Cost of revenue
-3,067
-3,018
-3,233
-3,566
-3,888
-3,869
-4,192
Cost of Goods & Services
0
0
0
0
0
0
0
Cost of Financing Revenue
0
0
0
0
0
0
0
Cost of Other Revenue
0
0
0
0
0
0
0
Gross Profit
2,070
2,074
2,217
2,563
2,908
3,040
3,528
Other Operating Income
0
0
0
0
0
0
0
Operating Expenses
-1,371
-1,325
-1,369
-1,509
-1,794
-1,916
-2,208
Selling, General & Administrative
-1,053
-1,050
-1,087
-1,215
-1,392
-1,409
-1,626
Selling & Marketing
0
0
0
0
0
0
0
General & Administrative
0
0
0
0
0
0
0
Research & Development
-317
-275
-282
-295
-401
-508
-582
Depreciation & Amortization
0
0
0
0
0
0
0
Provision For Doubtful Accounts
0
0
0
0
0
0
0
Other Operating Expense
0
0
0
0
0
0
0
Operating Income (Loss)
700
749
849
1,054
1,115
1,124
1,321
Non-Operating Income (Loss)
-369
-296
-366
-351
-305
-388
-378
Interest Expense, net
-381
-318
-331
-336
-309
-313
-333
Interest Expense
0
0
0
0
0
0
0
Interest Income
0
0
0
0
0
0
0
Other Investment Income (Loss)
0
0
0
0
0
0
0
Foreign Exchange Gain (Loss)
0
0
0
0
0
0
0
Income (Loss) from Affiliates
0
0
0
0
0
0
0
Other Non-Operating Income (Loss)
11
22
-34
-15
4
-75
-45
Pretax Income (Loss), Adjusted
330
453
483
703
809
736
942
Abnormal Gains (Losses)
-402
-226
-127
-49
-5
12
32
Acquired In-Process R&D
0
0
0
0
0
0
0
Merger / Acquisition Expense
0
0
0
0
0
0
0
Abnormal Derivatives
0
0
0
0
0
0
0
Disposal of Assets
0
0
0
0
0
0
0
Early extinguishment of Debt
0
0
0
0
0
0
0
Asset Write-Down
0
0
0
0
0
0
0
Impairment of Goodwill & Intangibles
0
0
0
0
0
0
0
Sale of Business
0
0
0
0
0
0
0
Legal Settlement
0
0
0
0
0
0
0
Restructuring Charges
0
0
0
0
0
0
0
Sale of and Unrealized Investments
0
0
0
0
0
0
0
Insurance Settlement
0
0
0
0
0
0
0
Other Abnormal Items
0
0
0
0
0
0
0
Pretax Income (Loss)
-72
227
356
655
804
747
975
Income Tax (Expense) Benefit, net
-129
21
-10
-116
-161
-121
-41
Current Income Tax
0
0
0
0
0
0
0
Deferred Income Tax
0
0
0
0
0
0
0
Tax Allowance/Credit
0
0
0
0
0
0
0
Income (Loss) from Affiliates, net of taxes
0
0
0
0
0
0
0
Income (Loss) from Continuing Operations
-200
248
346
539
643
627
933
Net Extraordinary Gains (Losses)
0
0
0
0
0
0
0
Discontinued Operations
0
0
0
0
0
0
0
XO & Accounting Charges & Other
0
0
0
0
0
0
0
Income (Loss) Including Minority Interest
-200
248
346
539
643
627
933
Minority Interest
4
-15
0
-2
-2
-3
-4
Net Income
-196
233
345
537
641
624
929
Preferred Dividends
-139
-139
-122
0
0
0
0
Other Adjustments
0
0
0
0
0
0
0
Net Income Available to Common Shareholders
-335
94
224
537
641
624
929
Remarks
restated on Feb 24, 2011 n/a
calculated values,
restated on Feb 21, 2012 n/a
calculated values,
restated on Feb 28, 2013 n/a
calculated values,
restated on Feb 27, 2014 n/a
calculated values,
restated on Mar 2, 2015 n/a
calculated values,
restated on Mar 2, 2015 n/a
calculated values,
restated on Mar 2, 2015 n/a
calculated values,
Balance SheetBS data quality: 100% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
No data available for the selected time periods
in million USD FY '08FY '09FY '10FY '11FY '12FY '13FY '14
Assets
Cash, Cash Equivalents & Short Term Investments
n/a
408
691
375
350
291
226
Cash & Cash Equivalents
n/a
381
662
375
350
291
226
Short Term Investments
n/a
28
29
0
0
0
0
Accounts & Notes Receivable
n/a
1,235
1,157
1,426
1,554
1,820
2,269
Accounts Receivable, Net
n/a
1,235
1,157
1,426
1,554
1,820
2,269
Notes Receivable, Net
n/a
0
0
0
0
0
0
Unbilled Revenues
n/a
0
0
0
0
0
0
Inventories
n/a
1,114
1,240
1,397
1,525
1,657
1,651
Raw Materials
n/a
0
0
0
0
0
0
Work In Process
n/a
0
0
0
0
0
0
Finished Goods
n/a
0
0
0
0
0
0
Other Inventory
n/a
0
0
0
0
0
0
Other Short Term Assets
n/a
528
471
371
473
703
2,642
Prepaid Expenses
n/a
232
188
168
244
453
2,296
Derivative & Hedging Assets
n/a
0
0
0
0
0
0
Assets Held-for-Sale
n/a
0
0
0
0
0
0
Deferred Tax Assets
n/a
249
259
203
229
250
346
Income Taxes Receivable
n/a
0
0
0
0
0
0
Discontinued Operations
n/a
0
0
0
0
0
0
Miscellaneous Short Term Assets
n/a
48
24
0
0
0
0
Total Current Assets
n/a
3,285
3,559
3,569
3,903
4,471
6,787
Property, Plant & Equipment, Net
n/a
1,123
1,209
1,298
1,397
1,666
1,786
Property, Plant & Equipment
n/a
0
0
0
0
0
0
Accumulated Depreciation
n/a
0
0
0
0
0
0
Long Term Investments & Receivables
n/a
0
0
0
0
0
0
Long Term Investments
n/a
0
0
0
0
0
0
Long Term Marketable Securities
n/a
0
0
0
0
0
0
Long Term Receivables
n/a
0
0
0
0
0
0
Other Long Term Assets
n/a
6,394
6,768
6,731
6,632
9,158
7,314
Intangible Assets
n/a
2,385
2,501
2,631
2,224
2,518
2,347
Goodwill
n/a
3,331
3,599
3,518
3,516
4,341
4,049
Other Intangible Assets
n/a
0
0
0
0
0
0
Prepaid Expense
n/a
0
0
0
0
0
0
Deferred Tax Assets
n/a
37
58
39
88
78
83
Derivative & Hedging Assets
n/a
0
0
0
0
0
0
Prepaid Pension Costs
n/a
0
0
0
0
0
0
Discontinued Operations
n/a
0
0
0
0
0
0
Investments in Affiliates
n/a
0
0
0
0
0
0
Miscellaneous Long Term Assets
n/a
641
609
543
804
2,222
834
Total Noncurrent Assets
n/a
7,516
7,977
8,029
8,029
10,824
9,100
Total Assets
n/a
10,802
11,537
11,598
11,932
15,295
15,887
Liabilities and owners' equity
Payables & Accruals
n/a
587 587374000
580 579812000
746 746115000
812 811639000
1,123 1122500000
1,066 1066300000
Accounts Payable
n/a
518 518252000
565 564706000
703 703235000
778 777908000
1,073 1072800000
906 905600000
Accrued Taxes
n/a
69 69122000
15 15106000
43 42880000
34 33731000
50 49700000
161 160700000
Interest & Dividends Payable
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Other Payables & Accruals
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Short Term Debt
n/a
194 193874000
170 169770000
820 819668000
397 397035000
443 443400000
2,805 2805100000
Short Term Borrowings
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Short Term Capital Leases
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Current Portion of Long Term Debt
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Other Short Term Liabilities
n/a
937 936899000
1,060 1060030000
997 997373000
985 984829000
1,398 1398100000
1,434 1434300000
Deferred Revenue
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Derivatives & Hedging
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Deferred Tax Liabilities
n/a
2 1986000
2 2457000
1 1215000
1 1283000
2 1500000
0 200000
Discontinued Operations
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Miscellaneous Short Term Liabilities
n/a
935 934913000
1,058 1057573000
996 996158000
984 983546000
1,397 1396600000
1,434 1434100000
Total Current Liabilities
n/a
1,718 1718147000
1,810 1809612000
2,563 2563156000
2,194 2193503000
2,964 2964000000
5,306 5305700000
Long Term Debt
n/a
4,985 4984987000
5,263 5263376000
4,479 4479080000
5,337 5337196000
7,587 7586500000
5,733 5732800000
Long Term Borrowings
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Long Term Capital Leases
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Other Long Term Liabilities
n/a
953 953402000
848 848415000
1,051 1051125000
1,045 1045370000
1,784 1784400000
1,572 1572100000
Accrued Liabilities
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Pension Liabilities
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Pensions
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Other Post-Retirement Benefits
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Deferred Compensation
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Deferred Revenue
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Deferred Tax Liabilities
n/a
467 467497000
478 478094000
309 308915000
274 274259000
515 515300000
235 235400000
Derivatives & Hedging
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Discontinued Operations
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Miscellaneous Long Term Liabilities
n/a
486 485905000
370 370321000
742 742210000
771 771111000
1,269 1269100000
1,337 1336700000
Total Noncurrent Liabilities
n/a
5,938 5938389000
6,112 6111791000
5,530 5530205000
6,383 6382566000
9,371 9370900000
7,305 7304900000
Total Liabilities
n/a
7,657 7656536000
7,921 7921403000
8,093 8093361000
8,576 8576069000
12,335 12334900000
12,611 12610600000
Preferred Equity
n/a
1 1070000
0 0
0 0
0 0
0 0
0 0
Share Capital & Additional Paid-In Capital
n/a
4,033 4033016000
4,113 4112591000
4,061 4060531000
4,257 4256578000
4,376 4375600000
4,486 4486100000
Common Stock
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Additional Paid in Capital
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Other Share Capital
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Treasury Stock
n/a
-1,575 -1574877000
-1,566 -1566289000
-1,901 -1901437000
-2,891 -2890732000
-3,879 -3878800000
-3,858 -3857700000
Retained Earnings
n/a
660 660130000
884 883710000
1,421 1420520000
2,061 2061370000
2,685 2685100000
3,615 3614500000
Other Equity
n/a
12 11807000
172 171867000
-88 -87839000
-86 -86498000
-240 -240100000
-987 -987000000
Equity Before Minority Interest
n/a
3,131 3131146000
3,602 3601879000
3,492 3491775000
3,341 3340718000
2,942 2941800000
3,256 3255900000
Minority Interest
n/a
14 14052000
14 13522000
13 13007000
15 15110000
18 18100000
20 20100000
Total Equity
n/a
3,145 3145198000
3,615 3615401000
3,505 3504782000
3,356 3355828000
2,960 2959900000
3,276 3276000000
Total Liabilities & Equity
n/a
10,802 10801734000
11,537 11536804000
11,598 11598143000
11,932 11931897000
15,295 15294800000
15,887 15886600000
Remarks restated on n/a restated on Feb 24, 2011 n/a restated on Feb 21, 2012 n/a restated on Feb 28, 2013 n/a restated on Feb 27, 2014 n/a restated on Mar 2, 2015 n/a restated on Mar 2, 2015 n/a
Cash Flow StatementCF data quality: 100% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
No data available for the selected time periods
in million USD FY '08FY '09FY '10FY '11FY '12FY '13FY '14
Net Income/Starting Line
-200
248
346
539
643
627
933
Net Income
0
0
0
0
0
0
0
Net Income From Discontinued Operations
0
0
0
0
0
0
0
Other Adjustments
0
0
0
0
0
0
0
Depreciation & Amortization
425
401
423
511
547
516
567
Non-Cash Items
351
221
306
141
432
453
697
Stock-Based Compensation
0
0
0
0
0
0
0
Deferred Income Taxes
0
0
0
0
0
0
0
Other Non-Cash Adjustments
0
0
0
0
0
0
0
Change in Working Capital
-191
-264
-142
-470
-673
-489
-1,182
(Increase) Decrease in Accounts Receivable
0
0
0
0
0
0
0
(Increase) Decrease in Inventories
0
0
0
0
0
0
0
Increase (Decrease) in Accounts Payable
0
0
0
0
0
0
0
Increase (Decrease) in Other
0
0
0
0
0
0
0
Net Cash From Discontinued Operations (operating)
0
0
0
0
0
0
0
Cash from Operating Activities
384
605
931
720
949
1,107
1,015
Change in Fixed Assets & Intangibles
-165
-154
-188
-280
-289
-309
-316
Disposition of Fixed Assets & Intangibles
0
0
0
0
0
0
0
Disposition of Fixed Assets
0
0
0
0
0
0
0
Disposition of Intangible Assets
0
0
0
0
0
0
0
Acquisition of Fixed Assets & Intangibles
0
0
0
0
0
0
0
Purchase of Fixed Assets
0
0
0
0
0
0
0
Acquisition of Intangible Assets
0
0
0
0
0
0
0
Other Change in Fixed Assets & Intangibles
0
0
0
0
0
0
0
Net Change in Long Term Investment
48
0
-3
-3
-2
-9
0
Decrease in Long Term Investment
0
0
0
0
0
0
0
Increase in Long Term Investment
0
0
0
0
0
0
0
Net Cash From Acquisitions & Divestitures
0
-237
-563
-81
0
-1,262
-50
Net Cash from Divestitures
0
0
0
0
0
0
0
Cash for Acqusition of Subsidiaries
0
0
0
0
0
0
0
Cash for Joint Ventures
0
0
0
0
0
0
0
Net Cash from Other Acquisitions
0
0
0
0
0
0
0
Other Investing Activities
-173
-83
-111
31
-73
-289
-434
Net Cash From Discontinued Operations (investing)
0
0
0
0
0
0
0
Cash from Investing Activities
-290
-474
-864
-332
-364
-1,869
-800
Dividends Paid
0
0
0
0
0
0
0
Cash From (Repayment of) Debt
83
-335
214
-352
227
1,636
-169
Cash From (Repayment of) Short Term Debt, net
0
0
0
0
0
0
0
Cash From (Repayment of) Long Term Debt, net
0
0
0
0
0
0
0
Repayments of Long Term Debt
0
0
0
0
0
0
0
Cash From Long Term Debt
0
0
0
0
0
0
0
Cash From (Repurchase of) Equity
64
20
55
-282
-856
-924
54
Increase in Capital Stock
0
0
0
0
0
0
0
Decrease in Capital Stock
0
0
0
0
0
0
0
Other Financing Activities
-176
0
-29
-11
18
-19
-153
Net Cash From Discontinued Operations (financing)
0
0
0
0
0
0
0
Cash from Financing Activities
-29
-315
239
-645
-612
693
-267
Net Cash Before Disc. Operations and FX
65
-184
306
-257
-27
-69
-53
Change in Cash from Disc. Operations and Other
0
0
0
0
0
0
0
Net Cash Before FX
65
-184
306
-257
-27
-69
-53
Effect of Foreign Exchange Rates
8
8
-25
-30
2
11
-13
Net Changes in Cash
73
-177
282
-287
-25
-59
-66
Remarks
restated on Feb 24, 2011 n/a
calculated values,
restated on Feb 21, 2012 n/a
calculated values,
restated on Feb 28, 2013 n/a
calculated values,
restated on Feb 27, 2014 n/a
calculated values,
restated on Mar 2, 2015 n/a
calculated values,
restated on Mar 2, 2015 n/a
calculated values,
restated on Mar 2, 2015 n/a
calculated values,
Some of the data shown on this page is provided for free by IEX
Sumo